Company intelligence / Profile preview

CannaCorp

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

CannaCorp is a life sciences and biotechnology company focused on the development of pharmaceutical-grade cannabinoid-based therapies. The company leverages advanced extraction and formulation technologies to create standardized, high-purity medicinal products targeting neurological and inflammatory conditions. CannaCorp's business model integrates research and development with specialized manufacturing to address unmet medical needs in chronic pain management and seizure disorders. By focusing on clinical-grade consistency, the company aims to bridge the gap between traditional herbal cannabis and regulated pharmaceutical medicine.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant-derived extract
Industry: Biotech

Beyond the preview

Go deeper on CannaCorp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CannaCorp.

Explore the full profile